Psychopharmacology in Oncology and Palliative Care 2014
DOI: 10.1007/978-3-642-40134-3_4
|View full text |Cite
|
Sign up to set email alerts
|

Psychological Assessment in Psychopharmacology

Abstract: A key element of supportive care is the reliable measurement of psychological health and psychosocial problems. This may include detection and measurement of frank psychiatric disorders as well as broader psychological symptoms and generalised distress. Many organisations have made recommendations for assessment of distress but despite the potential benefits uptake has been slow and evidence mixed. There is however momentum building for multi-domain screening for distress as the 6th vital sign. Psychosocial as… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 76 publications
(68 reference statements)
0
3
0
Order By: Relevance
“…As reported by Mitchell et al (2011) and Mitchell and Bultz (2014) a number of data have been accumulated regarding the screening for depression and anxiety, with the Depression in Cancer Consensus Group reporting diagnostic validity studies involving at least 19 tools designed to help clinicians identify depression in cancer settings ( Mitchell et al, 2012 ). Two stem questions derived form the Patient Health Questionnaire (PHQ-2), the Beck Depression Inventory (BDI-II) where considered acceptable.…”
Section: Screening For Emotional Disordersmentioning
confidence: 99%
See 2 more Smart Citations
“…As reported by Mitchell et al (2011) and Mitchell and Bultz (2014) a number of data have been accumulated regarding the screening for depression and anxiety, with the Depression in Cancer Consensus Group reporting diagnostic validity studies involving at least 19 tools designed to help clinicians identify depression in cancer settings ( Mitchell et al, 2012 ). Two stem questions derived form the Patient Health Questionnaire (PHQ-2), the Beck Depression Inventory (BDI-II) where considered acceptable.…”
Section: Screening For Emotional Disordersmentioning
confidence: 99%
“…Cognitive disorders and impairment have been examined in cancer as possible consequences of treatment. Data regarding brief testing (bedside cognitive testing) exist with studies evaluating the sensitivity/specificity of well-known instruments, including the Mini-Mental State Examination (MMSE), which seems to be less accurate than other tools, the Addenbrooke’s Cognitive Assessment – Revised (ACE-R), the abbreviated mental test score (AMTS), and 6-item cognitive impairment test (6CIT; Mitchell and Bultz, 2014 ).…”
Section: Screening For Emotional Disordersmentioning
confidence: 99%
See 1 more Smart Citation